AtriCure Reports Fourth Quarter and Full Year 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Piper Jaffray Reiterates Outperform as AtriCure (ATRC) Reports Strong 4Q Results
February 24, 2016 10:10 AM ESTPiper Jaffray maintained an Overweight rating on AtriCure Inc. (NASDAQ: ATRC), and cut the price target to $22.00 (from $25.00), following the company's 4Q earnings report. ATRC reported revenues that came in-line with it's Januarys pre-announcement. The loss per share was a little less than expected, due to lower-than-expected R&D expenses.
Analyst... More
AtriCure (ATRC) Reports In-Line Q4 EPS
February 23, 2016 4:40 PM ESTAtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.36), in-line with the analyst estimate of ($0.36). Revenue for the quarter came in at $35.9 million versus the consensus estimate of $35.89 million.
We are pleased to report strong 2015 results, positioning us well in 2016 as we continue to execute on... More
